Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of thiazole-pyrazoline derivatives in preparation of medicine for resisting non-small cell lung cancer

A non-small cell lung cancer, thiazole technology, applied in the application field of thiazole-pyrazoline derivatives in the preparation of anti-non-small cell lung cancer drugs, to achieve the effect of inhibiting the growth of A549 cancer cells and promoting the autophagy of A549 cells

Pending Publication Date: 2020-08-14
THE SECOND HOSPITAL OF SHANDONG UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

After searching, the relevant fluorescent compound 2-(3-(4-chlorophenyl)-5-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl)-4- The application of (pyridin-4-yl)thiazole in the preparation of anti-lung cancer drugs that promote autophagy of A549 cells and inhibit the growth of A549 cancer cells has not been reported

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of thiazole-pyrazoline derivatives in preparation of medicine for resisting non-small cell lung cancer
  • Application of thiazole-pyrazoline derivatives in preparation of medicine for resisting non-small cell lung cancer
  • Application of thiazole-pyrazoline derivatives in preparation of medicine for resisting non-small cell lung cancer

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0041] Example 1: Detection of survival rate by SRB method after CPT treatment of A549 cells.

[0042] (1) Add different concentrations of the compound CPT to treat the cells pre-planted in 96-well plates. (2) After compound treatment for 24 hours and 48 hours, the old culture medium was discarded, 100 μL of trichloroacetic acid was added, and the cells were fixed at 4° C. for 1 hour. (3) Discard the fixative. Wash five times with double-distilled water in gentle motions, and dry at room temperature. (4) Add 50 μL of SRB to each well, shake at room temperature for 10 minutes. (5) Wash 5 times with 1% acetic acid and dry at room temperature. (6) Add 100 μL of 10 mM buffer solution Tris base to each well and place on a shaker for 10 minutes. (7) Select 540nm excitation light to measure OD value.

[0043] The results show that: 5μM, 10μM CPT treatment of A549 cells for 24h and 48h can significantly inhibit the survival of A549 cells, see figure 1 .

Embodiment 2

[0044]Example 2: After A549 cells were treated with CPT, changes in cell morphology and number were detected under an inverted microscope.

[0045] A549 cells were seeded in a 6 cm-diameter petri dish at 37°C in CO 2 After culturing in the incubator for 12 hours, different concentrations of CPT were added for 12 hours, 24 hours and 48 hours, and then placed under an inverted microscope to photograph the cell morphology and observe the number of cells.

[0046] The results showed that: under the above conditions, 5μM and 10μM CPT could change the cell morphology, and some cells showed changes such as narrow, narrow, elongated and rounded, which significantly reduced the number of A549 cells. See figure 2 .

Embodiment 3

[0047] Example 3: After A549 cells were treated with different concentrations of CPT, the level of autophagy was detected by western blot.

[0048] A549 cells were seeded in a 6 cm-diameter petri dish at 37°C in CO 2 After culturing in the incubator for 12 hours, add different concentrations of CPT to treat for 24 hours, lyse the cells, collect the cell lysate, centrifuge at 12000g for 15 minutes at 4°C, take the supernatant, and use western blot to detect LC3B-I and LC3B-II in the cells treated in different ways protein level.

[0049] The results showed that: A549 cells were treated with 1 μM, 5 μM, and 10 μM CPT for 24 hours, which significantly promoted the increase of LC3B-Ⅱ levels and promoted the autophagy of A549 cells. See image 3 .

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an application of a compound 2-(3-(4-chlorphenyl)-5-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazole-1-yl)-4-(pyridine-4-yl)thiazole in the preparation of a medicine for resisting a non-small cell lung cancer. Experiments prove that the compound CPT provided by the invention can obviously inhibit the growth of A549 cells, and the inhibition effect is superior to that of a clinicaldrug 5-FU; and CPT can significantly promote autophagy of the A549 cells in a concentration and time dependent manner. The compound is expected to serve as an effective tool for inhibiting tumor growth and lays a foundation for developing the medicines for treating the non-small cell lung cancer.

Description

technical field [0001] The present invention relates to the application of thiazole-pyrazoline derivatives in the preparation of anti-lung cancer drugs, in particular to the fluorescent compound 2-(3-(4-chlorophenyl)-5-(4-methoxyphenyl)-4 , 5-dihydro-1H-pyrazol-1-yl)-4-(pyridin-4-yl)thiazole (abbreviated as CPT) in the preparation of anti-non-small cell Use in lung cancer drugs. Background technique [0002] At present, cancer is one of the three major diseases other than heart disease and cerebrovascular disease. Among the pains of more than a hundred different diseases, no effective treatment method has been found so far. Due to its late detection and high mortality rate, lung cancer has become a global problem in cancer treatment. Environmental factors, especially air pollution and unhealthy living habits such as smoking, also aggravate the development of lung cancer. Among them, non-small cell lung cancer accounts for about 85% of all lung cancers, and about 75% of th...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/4439A61P35/00
CPCA61K31/4439A61P35/00
Inventor 林兆民张明高冬芳张璐陈元王鹏林御星
Owner THE SECOND HOSPITAL OF SHANDONG UNIV